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SUPPLEMENTARY MATERIALS MATERIALS AND METHODS
Zebrafish: AB and Tg(gutGFP) s854 embryos were collected and staged under standard laboratory conditions.
Morpholino antisense oligonucleotides (MO):
MOs (GeneTools) were designed against the start ATG for both cxcl12b (12bMO: 5`GCGCTACTACTTTGCTATCCATGCC-3`) and cxcr4a (4aMO: 5` AGACGATGTGTTCGTAATAAGCCAT -3`) and were injected into 1-cell stage embryos at 10 ng for all experiments. The efficacy of each MO was tested by fusing the MO-target sequence upstream of eGFP. These constructs were injected either alone, or co-injected with the corresponding MO and knockdown of eGFP in MO-injected embryos was assayed in live embryos at 24 hpf (Fig. S1) . A fluoresceintagged 4aMO (4aMO-F), which gave identical phenotypes to the untagged 4aMO, was used for the endoderm-targeted mosaic experiments.
In situ hybridizations: Whole mount RNA in situ hybridizations were done as previously described (S1).
Endoderm-targeted mosaics: Donor AB embryos were co-injected with 500 pg of TARAM-A mRNA (S2) and 3% tetramethyl-rhodamine isothiocyanate (red). A second group of donors were co-injected with 500 pg of TARAM-A mRNA and 10 ng of 4aMO-F (green). Cells from both donors were co-transplanted into AB hosts at 4 hpf and imaged within 1 hour of transplantation and again at 8 hpf. Host embryos were raised to [24] [25] [26] [27] [28] [29] [30] hpf to confirm targeting of donor cells to the endoderm and only these embryos were taken into account for analysis.
RGD peptide treatments: RGD peptide (Sigma #G1269) was reconstituted to 4 mM in filter-sterilized embryo medium without methylene blue. AB or Tg(gutGFP) s854 transgenic embryos were dechorionated and treated with 400 µl of the peptide at 1 mM in embryo medium at 8-cell or at 6 hpf and were fixed for foxa2 and hand2 in situs or confocal imaged at 56 hpf to visualize the gut.
RNA rescue: itgb1b was cloned into pCS2, linearized with NotI and sense mRNA synthesized using SP6 polymerase (mMessage mMachine kit, Ambion). AB, 12b and 4a morphants were injected with 50, 75 and 100 pg of itgb1b mRNA and rescue of foxa2 expression to a single intestinal rod was assayed at 30 hpf.
Cell adhesion assay: AB and cxcr4a morphant embryos were injected at the 1-cell stage with 500 pg of TARAM-A mRNA and/or 100pg of itgb1b mRNA and raised to 4.3 hpf.
60-100 embryos were manually dechorionated in embryo medium with penicillinstreptomycin and dissociated into single cells (S3) in a 750 !l volume. Adhesion chambers were made by placing press-to-seal silicon insulators (20mm x 2.5 mm) onto plastic petridishes and coated with 10!g/ml fibronectin (Sigma) at 28 o C for 4 hrs prior to use. The entire cell suspension was seeded into the chambers and incubated at 28 o C for 3 2.5 hrs. Non-adhered cells were washed away by gently immersing the petridish in a beaker containing DMEM and placing it on a horizontal rotator for 5 mins. Average numbers of control and cxcr4a morphant cells that were stuck to the surface were counted by imaging 15 random, non-overlapping areas of each dish and averaged over 3 independent experiments.
Quantitative RT-PCR: AB embryos were injected with either cxcl12b or cxcr4a morpholinos (experiment 1) and also with 500 pg of TARAM-A mRNA (experiments 2 and 3). Total RNA was extracted using TRIZOL reagent and cDNA synthesized using 
